Furiex ready to progress MuDelta for IBS to Phase III
08 September 2011
Pial Ganguli
Please Login to read the full article.
08 September 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Salix presents data to expand markets for bowel disorder drugs Xifaxan and Relistor
- Actelion declines Trophos option as olesoxime crashes in Phase III
- Ocera secures CE mark and seeks partners for IBS therapy Zysa
- Tiny Tioga attracts $10m and new investor for Phase III asimadoline clinical trial
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
